Brain Stimulation for Speech Learning
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how the brain learns and remembers speech using transcranial magnetic stimulation (TMS). Researchers focus on the roles of different brain areas, such as those for hearing, touch, and movement, in learning and retaining speech skills. Participants will undergo brain stimulation, specifically with continuous theta-burst stimulation (cTBS), while performing speech tasks to assess its impact on their ability to learn and remember. This trial may suit right-handed, fluent English speakers with normal hearing and no speech or reading issues. As an unphased trial, it offers a unique opportunity to contribute to groundbreaking research on brain function and speech learning.
Will I have to stop taking my current medications?
The trial excludes participants who are taking psychoactive medications, so you would need to stop taking those to participate. For other medications, the protocol does not specify.
What prior data suggests that this brain stimulation technique is safe for speech learning?
Research has shown that continuous theta-burst stimulation (cTBS) is generally safe. Studies have found that cTBS, used to treat conditions like auditory hallucinations in schizophrenia and tinnitus, does not cause major side effects. For example, one study found that applying cTBS to brain areas involved in hearing and speech was safe and did not impair these functions.
In another study on learning to speak, cTBS was used without any serious side effects. Overall, these findings suggest that cTBS is a safe option for similar research. However, as with any treatment, individual experiences may vary, so discussing any concerns with the study staff or a healthcare provider is important.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how continuous theta-burst stimulation (cTBS) can enhance speech learning by targeting specific brain regions. Unlike traditional speech therapy that focuses on exercises and practice over time, cTBS offers a unique approach by directly stimulating the auditory, somatosensory, or motor cortex. This method could accelerate learning and retention by directly influencing brain activity patterns. The trial aims to uncover how these targeted stimulations improve speech learning, potentially offering a more efficient and effective way to address speech disorders.
What evidence suggests that this trial's treatments could be effective for speech learning?
Studies have shown that continuous theta-burst stimulation (cTBS) can improve speech and sound comprehension. Research indicates that applying cTBS to certain brain areas can significantly enhance speech understanding and conditions like aphasia, which affects speaking and comprehension. Additionally, cTBS is considered safe for hearing and speech perception. In this trial, participants will receive cTBS applied to different brain areas, such as the auditory, somatosensory, or motor cortex, with either altered or unaltered auditory feedback. This approach suggests that targeting specific brain areas with cTBS might aid in learning and remembering new speech patterns. Overall, early findings are promising for using cTBS in learning and retaining speech skills.25678
Who Is on the Research Team?
David Ostry
Principal Investigator
Yale University
Are You a Good Fit for This Trial?
This trial is for right-handed, fluent English speakers with normal hearing and no speech disorders or reading disabilities. It's not suitable for individuals with a cardiac pacemaker, cochlear implant, tinnitus, metal implants in the brain or body, history of epilepsy or severe head injuries, those who are pregnant or on psychoactive medications.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants perform learning tasks with altered or unaltered auditory feedback, followed by cTBS to specific brain regions. This is repeated on day 2.
Retention Assessment
Participants return 24 hours after treatment to assess retention of learning.
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Adaptation
- continuous theta-burst stimulation (cTBS)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator